Teva Pharmaceutical Industries Ltd. is preparing for a potential reckoning with the U.S. epidemic of opioid addiction. The drugmaker’s shares tumbled after it set aside $646 million to help pay legal expenses related to its alleged role in the abuse …
Source: Claims Journal